7 August 2019Curaleaf (CURA.C) facing class-action lawsuits following FDA warning letterEthan Reyes CURA.C Curaleaf (CURA.C), the CSE-listed, U.S.-based multi-state operator (MSO), is now the target of several class-action lawsuits concerning the sale of products in violation of FDA regulations. Lawsuits by at…